Abstract:Purpose: Oxymatrine, an alkaloid extracted from the Chinese herb Sophora flavescens Aiton, possesses anti-inflammatory, anti-immune, anti-hepatic fibrosis, and anti-cancer properties. However, the effects of oxymatrine on epithelial-mesenchymal transition (EMT) of breast cancer cells are still unclear. Aim: The present study was performed to investigate whether oxymatrine reverses EMT in breast cancer cells and to explore the underlying molecular mechanisms. Materials and methods: MTT assay was performed to evaluate cell viability. Wound-healing assay and transwell chamber assay were used to assess cell migration and invasion, respectively. Immunofluorescence and Western blot were used to study the expression of EMT-related molecules and alpha(V)beta(3) integrin/focal adhesion kinase (FAK)/phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling transduction. Fibronectin, a physiologic ligand of alpha(V)beta(3) integrin, was used to stimulate alpha(V)beta(3) integrin signaling. Results: Our results demonstrated that oxymatrine effectively suppressed the viability of MDA-MB-231 and 4T1 breast cancer cells, and oxymatrine showed less cytotoxicity on normal breast mammary epithelial MCF-10A cells. In addition, oxymatrine reversed EMT in the MDA-MB-231 and 4T1 cells at nontoxic concentrations. Oxymatrine significantly inhibited cell migration and invasion, downregulated the expression of N-cadherin, vimentin, and Snail in MDA-MB-231 and 4T1 cells, but upregulated the expression of E-cadherin in 4T1 cells. The mechanism revealed that oxymatrine decreased the expression of alpha(V) and beta(3) integrin and their co-localization. It also inhibited alpha(V)beta(3) integrin downstream activation by suppressing the phosphorylation of FAK, PI3K, and Akt. Furthermore, oxymatrine prevented fibronectin-induced EMT and alpha(V)beta(3) integrin/FAK/PI3K/Akt signaling activation. Conclusion: Our results revealed that oxymatrine effectively reversed EMT in breast cancer cells by depressing alpha(V)beta(3) integrin/FAK/PI3K/Akt signaling. Thus, oxymatrine could be a potential therapeutic candidate with anti-metastatic potential for the treatment of breast cancer.

Oxymatrine induces apoptosis in non-small cell lung cancer cells by downregulating TRIM46

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Oxymatrine Induces A549 Human Non‑small Lung Cancer Cell Apoptosis Via Extrinsic and Intrinsic Pathways.

Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion

Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG/HOS cells through inhibition of PI3K/Akt pathway

Oxymatrine Promotes S-Phase Arrest and Inhibits Cell Proliferation of Human Breast Cancer Cells in Vitro Through Mitochondria-Mediated Apoptosis.

Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c

Oxymatrine (OMT) Inhibits Lung Cancer Growth through Mitogen Activated Protein Kinase JNK/ERK/p38MAPKs Activation

Oxymatrine Inhibits the Development of Non-Small Cell Lung Cancer Through Mir-367-3p Upregulation and Target Gene SGK3 Downregulation.

RETRACTED: Effects of Oxymatrine on the Proliferation and Apoptosis of Human Hepatoma Carcinoma Cells

Oxymatrine Inhibits Non-Small Cell Lung Cancer Via Suppression of EGFR Signaling Pathway

Oxymatrine triggers apoptosis by regulating Bcl-2 family proteins and activating caspase-3/caspase-9 pathway in human leukemia HL-60 cells

Oxymatrine and Cancer Therapy

Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells.

Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α Ⅴ β 3 integrin/FAK/PI3K/Akt signaling activation.

Matrine Induces the Apoptosis of Lung Cancer Cells Through Downregulation of Inhibitor of Apoptosis Proteins and the Akt Signaling Pathway

Oxymatrine Induces Apoptosis in Human Myeloma Cells by Cell Cycle Arrest and Activation of Caspase-Dependent Apoptosis

Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo

Oxymatrine inhibits melanoma development by modulating the immune microenvironment and targeting the MYC/PD-L1 pathway

Matrine Induction of Reactive Oxygen Species Activates P38 Leading to Caspase-Dependent Cell Apoptosis in Non-Small Cell Lung Cancer Cells.

Oxymatrine Inhibits the Development of Radioresistance in NSCLC Cells by Reversing EMT Through the DcR3/AKT/GSK-3β Pathway